Home LiteratureArticle Details
PMID: 16987985 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Crystal structure of the West Nile virus envelope glycoprotein.

Journal of virology ·Vol. 80 ·No. 23 ·2006-12-00 ·Pages 11467-74

Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH

Abstract

The envelope glycoprotein (E) of West Nile virus (WNV) undergoes a conformational rearrangement triggered by low pH that results in a class II fusion event required for viral entry. Herein we present the 3.0-A crystal structure of the ectodomain of WNV E, which reveals insights into the flavivirus life cycle. We found that WNV E adopts a three-domain architecture that is shared by the E proteins from dengue and tick-borne encephalitis viruses and forms a rod-shaped configuration similar to that observed in immature flavivirus particles. Interestingly, the single N-linked glycosylation site on WNV E is displaced by a novel alpha-helix, which could potentially alter lectin-mediated attachment. The localization of histidines within the hinge regions of E implicates these residues in pH-induced conformational transitions. Most strikingly, the WNV E ectodomain crystallized as a monomer, in contrast to other flavivirus E proteins, which have crystallized as antiparallel dimers. WNV E assembles in a crystalline lattice of perpendicular molecules, with the fusion loop of one E protein buried in a hydrophobic pocket at the DI-DIII interface of another. Dimeric E proteins pack their fusion loops into analogous pockets at the dimer interface. We speculate that E proteins could pivot around the fusion loop-pocket junction, allowing virion conformational transitions while minimizing fusion loop exposure.

MeSH Terms
Animals Baculoviridae Cell Line Viral Envelope Proteins/biosynthesis,chemistry West Nile virus/chemistry,metabolism
Chemicals
Viral Envelope Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Nybakken Grant E
Department of Pathology & Immunology, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Avenue, St. Louis, MO 63110-1093, USA.
Nelson Christopher A
Chen Beverly R
Diamond Michael S
Fremont Daved H
References (46)
46 references, click to expand
  1. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.
    J Virol. 2001 May;75(9):4268-75 PMID: 11287576
  2. Dengue and other emerging flaviviruses.
    J Infect. 2001 Feb;42(2):104-15 PMID: 11531316
  3. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.
    Cell. 2002 Mar 8;108(5):717-25 PMID: 11893341
  4. The molecular biology of West Nile Virus: a new invader of the western hemisphere.
    Annu Rev Microbiol. 2002;56:371-402 PMID: 12142476
  5. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.
    J Virol. 2002 Dec;76(24):13097-100 PMID: 12438639
  6. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.
    J Exp Med. 2003 Apr 7;197(7):823-9 PMID: 12682107
  7. A ligand-binding pocket in the dengue virus envelope glycoprotein.
    Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91 PMID: 12759475
  8. Structures of immature flavivirus particles.
    EMBO J. 2003 Jun 2;22(11):2604-13 PMID: 12773377
  9. Involvement of lipids in different steps of the flavivirus fusion mechanism.
    J Virol. 2003 Jul;77(14):7856-62 PMID: 12829825
  10. Structure of West Nile virus.
    Science. 2003 Oct 10;302(5643):248 PMID: 14551429
  11. Structure of the dengue virus envelope protein after membrane fusion.
    Nature. 2004 Jan 22;427(6972):313-9 PMID: 14737159
  12. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.
    EMBO J. 2004 Feb 25;23(4):728-38 PMID: 14963486
  13. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus.
    J Biol Chem. 2004 Sep 10;279(37):38755-61 PMID: 15190071
  14. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.
    Nat Struct Mol Biol. 2004 Jul;11(7):591-8 PMID: 15195147
  15. Effect of membrane curvature-modifying lipids on membrane fusion by tick-borne encephalitis virus.
    J Virol. 2004 Aug;78(16):8536-42 PMID: 15280462
  16. The CCP4 suite: programs for protein crystallography.
    Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 PMID: 15299374
  17. West Nile virus: where are we now?
    Lancet Infect Dis. 2004 Sep;4(9):547-56 PMID: 15336221
  18. Conformational changes of the flavivirus E glycoprotein.
    Structure. 2004 Sep;12(9):1607-18 PMID: 15341726
  19. Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus.
    J Gen Virol. 2004 Dec;85(Pt 12):3637-45 PMID: 15557236
  20. A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion.
    J Virol. 2004 Dec;78(24):13543-52 PMID: 15564465
  21. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes.
    J Virol. 2004 Dec;78(24):13975-86 PMID: 15564505
  22. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.
    J Virol. 2005 Jan;79(2):1223-31 PMID: 15613349
  23. Ligand recognition by antigen-presenting cell C-type lectin receptors.
    Curr Opin Immunol. 2005 Feb;17(1):18-24 PMID: 15653305
  24. Genome sequence and attenuating mutations in West Nile virus isolate from Mexico.
    Emerg Infect Dis. 2004 Dec;10(12):2221-4 PMID: 15663867
  25. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
    Nat Med. 2005 May;11(5):522-30 PMID: 15852016
  26. Characterization of neutralizing antibodies to West Nile virus.
    Virology. 2005 May 25;336(1):70-82 PMID: 15866072
  27. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.
    J Virol. 2005 Jul;79(13):8339-47 PMID: 15956579
  28. Structural basis of West Nile virus neutralization by a therapeutic antibody.
    Nature. 2005 Sep 29;437(7059):764-9 PMID: 16193056
  29. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion.
    J Cell Biol. 2005 Oct 10;171(1):111-20 PMID: 16216925
  30. N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity.
    J Virol. 2005 Nov;79(21):13262-74 PMID: 16227249
  31. Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus.
    Structure. 2006 Jan;14(1):75-86 PMID: 16407067
  32. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.
    Annu Rev Med. 2006;57:181-94 PMID: 16409144
  33. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.
    J Virol. 2006 Feb;80(3):1290-301 PMID: 16415006
  34. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.
    Cell. 2006 Feb 10;124(3):485-93 PMID: 16469696
  35. Improved methods for building protein models in electron density maps and the location of errors in these models.
    Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9 PMID: 2025413
  36. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation.
    Virology. 1990 Aug;177(2):668-75 PMID: 2371772
  37. Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release.
    J Virol. 1989 Jun;63(6):2521-6 PMID: 2724410
  38. Processing of X-ray diffraction data collected in oscillation mode.
    Methods Enzymol. 1997;276:307-26 PMID: 27754618
  39. Conditions for haemolysis by flaviviruses and characterization of the haemolysin.
    J Gen Virol. 1985 Oct;66 ( Pt 10):2291-6 PMID: 2995565
  40. Association between the pH-dependent conformational change of West Nile flavivirus E protein and virus-mediated membrane fusion.
    J Gen Virol. 1988 Jun;69 ( Pt 6):1247-54 PMID: 3385406
  41. pH-dependent fusion between the flavivirus West Nile and liposomal model membranes.
    J Gen Virol. 1986 Jan;67 ( Pt 1):157-66 PMID: 3944582
  42. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.
    Nature. 1995 May 25;375(6529):291-8 PMID: 7753193
  43. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM.
    Virology. 1994 Jan;198(1):109-17 PMID: 8259646
  44. Proteolytic activation of tick-borne encephalitis virus by furin.
    J Virol. 1997 Nov;71(11):8475-81 PMID: 9343204
  45. Crystallography & NMR system: A new software suite for macromolecular structure determination.
    Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21 PMID: 9757107
  46. West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness.
    J Gen Virol. 1998 Oct;79 ( Pt 10):2375-80 PMID: 9780042
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2006-12-00
Epub
2006-00-20
Pages
11467-74
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1642602
Subset
IM
Grants
NCRR NIH HHS · P41 RR007707 · United States
NIGMS NIH HHS · T32 GM008492 · United States
NIGMS NIH HHS · T32 GM 008492 · United States
NIAID NIH HHS · AI 061373 · United States
NIGMS NIH HHS · T32 GM 07200 · United States
NIGMS NIH HHS · T32 GM007200 · United States
NIAID NIH HHS · U01 AI061373 · United States
NCRR NIH HHS · RR 07707 · United States
Databases
PDB
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com